DrugPatentWatch Database Preview
Arbor Pharms Llc Company Profile
» See Plans and Pricing
What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has twenty-three approved drugs.
There are twenty-seven US patents protecting ARBOR PHARMS LLC drugs.
There are three hundred and fifteen patent family members on ARBOR PHARMS LLC drugs in forty-six countries and thirty-two supplementary protection certificates in seventeen countries.
Summary for Arbor Pharms Llc
| International Patents: | 315 |
| US Patents: | 27 |
| Tradenames: | 24 |
| Ingredients: | 15 |
| NDAs: | 23 |
Drugs and US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-001 | Oct 25, 2011 | RX | No | No | Start Trial | Start Trial | |||||
| Arbor Pharms Llc | ERYPED | erythromycin ethylsuccinate | GRANULE;ORAL | 050207-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Arbor Pharms Llc | EVEKEO ODT | amphetamine sulfate | TABLET, ORALLY DISINTEGRATING;ORAL | 209905-002 | Jan 30, 2019 | RX | Yes | No | 10,441,554 | Start Trial | Y | Start Trial | |||
| Arbor Pharms Llc | HORIZANT | gabapentin enacarbil | TABLET, EXTENDED RELEASE;ORAL | 022399-001 | Apr 6, 2011 | RX | Yes | Yes | 8,026,279 | Start Trial | Y | Y | Start Trial | ||
| Arbor Pharms Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-007 | Oct 25, 2011 | RX | No | No | Start Trial | Start Trial | |||||
| Arbor Pharms Llc | PEDIAMYCIN | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062304-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 5,179,189 | Start Trial |
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-001 | Dec 20, 2011 | 5,583,141 | Start Trial |
| Arbor Pharms Llc | BIDIL | hydralazine hydrochloride; isosorbide dinitrate | TABLET;ORAL | 020727-001 | Jun 23, 2005 | 6,465,463 | Start Trial |
| Arbor Pharms Llc | EDARBYCLOR | azilsartan kamedoxomil; chlorthalidone | TABLET;ORAL | 202331-002 | Dec 20, 2011 | 5,583,141 | Start Trial |
| Arbor Pharms Llc | GLIADEL | carmustine | IMPLANT;INTRACRANIAL | 020637-001 | Sep 23, 1996 | 4,757,128 | Start Trial |
| Arbor Pharms Llc | EDARBI | azilsartan kamedoxomil | TABLET;ORAL | 200796-001 | Feb 25, 2011 | 5,958,961 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2012507545 | Start Trial |
| Hungary | 0400167 | Start Trial |
| European Patent Office | 1857457 | Start Trial |
| Canada | 2666365 | Start Trial |
| Japan | 5001227 | Start Trial |
| Serbia | 51137 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1718641 | 12C0034 | France | Start Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/11/735/001 20111207 |
| 1718641 | 2012/008 | Ireland | Start Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTRATION NO/DATE: EU/1/11/734/001-011 EU/1/11/735/001-011 20111209 |
| 1620113 | CA 2015 00045 | Denmark | Start Trial | PRODUCT NAME: IVERMECTIN, 22, 23-DIHYDROAVERMECTINB1A + 22,23-DIHRODROAVERMECTIN B1B FOR USE IN THE TREATMNET OF RESACEA; NAT. REG. NO/DATE: 54123 20150422; FIRST REG. NO/DATE: MT MA 117/01101 20150402 |
| 1718641 | 1290016-3 | Sweden | Start Trial | PRODUCT NAME: AZILSARTANMEDOXOMIL OCH FARMACEUTISKT GODTAGBARA SALTER DAERAV, INKLUDERANDE KALIUMSALT; REG. NO/DATE: EU/1/11/735/001 20111207 |
| 1718641 | C01718641/01 | Switzerland | Start Trial | PRODUCT NAME: AZILSARTAN MEDOXOMIL; REGISTRATION NO/DATE: SWISSMEDIC 62158 31.08.2012 |
| 1620113 | C300756 | Netherlands | Start Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
